DUBLIN--(BUSINESS WIRE)--The "Global Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
Prader-Willi Syndrome therapeutics market is projected to display a robust growth represented by a CAGR of 4.6% during 2019 - 2024.
The report presents a comprehensive pipeline assessment that includes DCCR (Soleno Therapeutics), Levolitide (Millendo Therapeutics) and Tesomet (Saniona). Also, the report analyzes the prevalence of PWS and profiles the leading companies operating in the PWS Therapeutics market.
Over the recent years, the Prader-Willi Syndrome market has been witnessing considerable growth directly on the back of the increasing number of diagnosed patient's population. Moreover, growing human growth hormone therapy coverage rate, surging awareness and increasing government involvement have been driving the market.
Further, expected launch of novel therapies, such as DCCR (Soleno Therapeutics), Livoletide (Millendo Therapeutics), Testomet (Saniona AB) among others are anticipated to fuel the market growth.
The report titled report Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024) has covered and analyzed the potential of Prader-Willi Syndrome market and provides statistics and information on market size, shares and growth factors.
Scope of the Report
Global Prader-Willi Syndrome Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
- Prader-Willi Syndrome Market - Size, Growth, Forecast
- Prader-Willi Syndrome Market: Pipeline Analysis
- DCCR (Soleno Therapeutics)
- Levolitide (Millendo Therapeutics)
- Tesomet (Saniona)
Other Report Highlights
- Pipeline Analysis.
- Competitive Landscape.
- Product Benchmarking.
- Market Dynamics - Drivers and Restraints.
- Market Trends.
- Porter Five Forces Analysis.
- SWOT Analysis.
Company Analysis - Pfizer, Novartis, Novo Nordisk, Soleno Therapeutics, Saniona
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
3.1 Invest in Somatropin Biosimilar
3.2 Invest in Combination Therapy For PWS
4. Surgical Masks Product Outlook
5. Global Prader-Willi Syndrome Market: Growth and Forecast
5.1 By Value (2017-2018)
5.2 By Value (2019-2024)
6. Global Prader-Willi Syndrome Pipeline Analysis
6.1 DCCR Pipeline Analysis
6.2 Levolitide Pipeline Analysis
6.3 Tesomet Pipeline Analysis
7. Global Prader-Willi Syndrome Market, By Region
8. U.S.A Prader-Willi Syndrome Market
8.1 U.S.A Prader-Willi Syndrome Market Size (2017-2024F)
8.2 U.S.A Prader-Willi Syndrome Prevalence (2017-2024F)
9. Europe Prader-Willi Syndrome Market
9.1 Europe Prader-Willi Syndrome Market Size (2017-2024F)
9.2 Europe Prader-Willi Syndrome Prevalence (2017-2024F)
10. Japan Prader-Willi Syndrome Market
10.1 Japan Prader-Willi Syndrome Market Size (2017-2024F)
10.2 Japan Prader-Willi Syndrome Prevalence (2017-2024F)
11. Global Prader-Willi Syndrome Market - Competitive Landscape
12. Global Prader-Willi Syndrome Market - Product Benchmarking
13. Global Prader-Willi Syndrome Market: Market Dynamics
13.1 Global Prader-Willi Syndrome Market Drivers
13.2 Global Prader-Willi Syndrome Market Restrains
13.3 Global Prader-Willi Syndrome Market Trends
14. Porter Five Force Analysis
15. SWOT Analysis
16. Global Prader-Willi Syndrome Market: Regulatory Frameworks
17. Company Profiles
17.2 Novartis AG
17.3 Novo Nordisk
17.4 Soleno Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/1qb7d4